A new law that will increase access to lower-cost generic drugs and bolster competition within the generic drug marketplace to help reduce drug costs was sponsored by Rep. Robin Kelly, D-Ill., who represents Homewood and Flossmoor in Congress.
The Orange Book Transparency Act was signed into law by President Donald Trump on Jan. 5. The legislation passed by unanimous consent in both the House and Senate.
“Americans will finally get a break from astronomical drug…
